Cyclooxygenase-2 in Barrett's esophagus, Barrett's adenocarcinomas, and esophageal SCC: ready for clinical trials.

The American journal of gastroenterology

Volumn 94, Issue 8, 1999, Pages 2313-2315

  Lord, R V ^a   Danenberg, K D ^a   Danenberg, P V ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ISOENZYME; MEMBRANE PROTEIN; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS2 PROTEIN, HUMAN;

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; CANCER STAGING; CELL CULTURE; CLINICAL TRIAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PATHOLOGY; PRECANCER; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; NEOPLASM STAGING; NITRIC OXIDE SYNTHASE; PRECANCEROUS CONDITIONS; PROGNOSIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TUMOR CELLS, CULTURED;

EID: 0033173218     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.02313.x     Document Type: Article

References (0)